Unlock stock picks and a broker-level newsfeed that powers Wall Street.
32.53
-0.49
(-1.48%)
At close: April 1 at 4:00:01 PM EDT
32.53
0.00
(0.00%)
Pre-Market: 4:31:33 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 12 | 13 |
| Avg. Estimate | 0.3 | 0.48 | 1.84 | 1.82 |
| Low Estimate | 0.03 | 0.39 | 1.57 | 1.43 |
| High Estimate | 0.55 | 0.56 | 2.17 | 2.2 |
| Year Ago EPS | 0.43 | 0.7 | 2.89 | 1.84 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 15 | 15 | 16 |
| Avg. Estimate | 311.08M | 347.39M | 1.39B | 1.45B |
| Low Estimate | 292M | 335.7M | 1.37B | 1.35B |
| High Estimate | 340.99M | 358.34M | 1.42B | 1.59B |
| Year Ago Sales | 350.37M | 399.13M | 1.56B | 1.39B |
| Sales Growth (year/est) | -11.22% | -12.96% | -10.53% | 4.08% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.58 | 0.71 | 0.71 | 0.76 |
| EPS Actual | 0.43 | 0.7 | 0.73 | 1.05 |
| Difference | -0.15 | -0.01 | 0.02 | 0.29 |
| Surprise % | -26.20% | -0.79% | 2.43% | 37.62% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.3 | 0.48 | 1.84 | 1.82 |
| 7 Days Ago | 0.3 | 0.48 | 1.85 | 1.85 |
| 30 Days Ago | 0.34 | 0.47 | 1.76 | 1.77 |
| 60 Days Ago | 0.34 | 0.44 | 1.79 | 1.93 |
| 90 Days Ago | 0.36 | 0.46 | 1.83 | 1.98 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | -- | -- |
| Up Last 30 Days | -- | -- | 2 | -- |
| Down Last 7 Days | 1 | 2 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 5 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALKS | -30.79% | -32.00% | -36.40% | -0.84% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Deutsche Bank: Buy to Buy | 3/27/2025 |
| Initiated | RBC Capital: Sector Perform | 3/13/2025 |
| Upgrade | UBS: Sell to Neutral | 3/4/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/14/2025 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 2/13/2025 |
| Initiated | Deutsche Bank: Buy | 2/11/2025 |
Related Tickers
PCRX Pacira BioSciences, Inc.
24.07
-3.14%
NBIX Neurocrine Biosciences, Inc.
107.00
-3.25%
RDY Dr. Reddy's Laboratories Limited
13.16
-0.23%
ITCI Intra-Cellular Therapies, Inc.
131.87
-0.04%
COLL Collegium Pharmaceutical, Inc.
29.39
-1.54%
INDV.L Indivior PLC
731.00
-1.08%
AMRX Amneal Pharmaceuticals, Inc.
8.23
-1.79%
AMPH Amphastar Pharmaceuticals, Inc.
28.29
-2.41%
PRGO Perrigo Company plc
27.70
-1.21%
EGRX Eagle Pharmaceuticals, Inc.
1.5500
+58.16%